Abstract
Recently, TDP-43 was identified as a key component of ubiquitinated aggregates in amyotrophic lateral sclerosis (ALS), an adult-onset neurological disorder that leads to the degeneration of motor neurons. Here we report eight missense mutations in nine individuals—six from individuals with sporadic ALS (SALS) and three from those with familial ALS (FALS)—and a concurring increase of a smaller TDP-43 product. These findings further corroborate that TDP-43 is involved in ALS pathogenesis.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Modelling TDP-43 proteinopathy in Drosophila uncovers shared and neuron-specific targets across ALS and FTD relevant circuits
Acta Neuropathologica Communications Open Access 20 October 2023
-
TDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP
Nature Open Access 02 August 2023
-
A novel gene, TARDBP, and the protein it encodes can predict glioma patient prognosis and establish a prediction model
BMC Neurology Open Access 06 May 2023
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Lansbury, P.T. & Lashuel, H.A. Nature 443, 774–779 (2006).
Arai, T. et al. Biochem. Biophys. Res. Commun. 351, 602–611 (2006).
Mackenzie, I.R. et al. Ann. Neurol. 61, 427–434 (2007).
Neumann, M. et al. Science 314, 130–133 (2006).
Strong, M.J. et al. Mol. Cell. Neurosci. 35, 320–327 (2007).
Gijselinck, I. et al. Neurobiol. Aging (in press).
Greenway, M.J. et al. Nat. Genet. 38, 411–413 (2006).
Frey, S., Richter, R.P. & Gorlich, D. Science 314, 815–817 (2006).
Buratti, E. et al. J. Biol. Chem. 280, 37572–37584 (2005).
Ou, S.H., Wu, F., Harrich, D., Garcia-Martinez, L.F. & Gaynor, R.B. J. Virol. 69, 3584–3596 (1995).
Forman, M.S., Trojanowski, J.Q. & Lee, V.M. Curr. Opin. Neurobiol. 17, 548–555 (2007).
Wang, H.Y., Wang, I.F., Bose, J. & Shen, C.K. Genomics 83, 130–139 (2004).
Wang, I.F., Reddy, N.M. & Shen, C.K. Proc. Natl. Acad. Sci. USA 99, 13583–13588 (2002).
Amador-Ortiz, C. et al. Ann. Neurol. 61, 435–445 (2007).
Filimonenko, M. et al. J. Cell Biol. 179, 485–500 (2007).
Acknowledgements
We would like to thank all the families involved in this study. We also thank M. Benard, I. Thibault and P. Provencher for sample collection and organization, M. D'Amour and D. Brunet for providing access to their patients and A. Dyck and J. St-Onge for technical support. G.A.R. is funded by the Canadian Institutes of Health Research (CIHR), Muscular Dystrophy Association USA and ALS Association (ALSA), E.K. by ALS Canada and CIHR, N.D. by CIHR, P.N.V. by the Fonds de Recherche en Sante Quebec (FRSQ) and V.M. by the Association Francaise contre les Myopathies France (AMF) and the Association pour la Recherche sur la Sclerose Laterale Amyotrophique (ARS).
Author information
Authors and Affiliations
Contributions
E.K. and P.N.V. generated the data, conducted the data analysis, wrote the manuscript and led the project; P.D. participated in the data analysis and review of the manuscript; E.K. and P.D. conducted the functional analysis of lymphoblastoid cell lines derived from individuals with ALS; P.N.V. conducted haplotype and performed 3D modelling; D.S. performed sequence and data analysis; B.J.M. conducted bioinformatic analysis of mutations and reviewed the manuscript; C.V.V. performed functional analysis and reviewed the manuscript. J.-P.B., L.L., K.P., F.S., P.-F.P., W.C., V.M. and N.D. conducted neurological evaluation and family history of individuals with ALS and reviewed the manuscript. G.A.R. conducted neurological evaluation of individuals with ALS, participated in the data analysis, reviewed the manuscript and supervised the project.
Corresponding author
Supplementary information
Supplementary Text and Figures
Supplementary Tables 1–4, Supplementary Figures 1 and 2, Supplementary Note and Supplementary Methods (PDF 239 kb)
Rights and permissions
About this article
Cite this article
Kabashi, E., Valdmanis, P., Dion, P. et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 40, 572–574 (2008). https://doi.org/10.1038/ng.132
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.132
This article is cited by
-
Advances in sequencing technologies for amyotrophic lateral sclerosis research
Molecular Neurodegeneration (2023)
-
Modelling TDP-43 proteinopathy in Drosophila uncovers shared and neuron-specific targets across ALS and FTD relevant circuits
Acta Neuropathologica Communications (2023)
-
The era of cryptic exons: implications for ALS-FTD
Molecular Neurodegeneration (2023)
-
A novel gene, TARDBP, and the protein it encodes can predict glioma patient prognosis and establish a prediction model
BMC Neurology (2023)
-
Nutritional and metabolic factors in amyotrophic lateral sclerosis
Nature Reviews Neurology (2023)
